Delivery Order SPE2DB22D1202-SPE2DB24FVGC8

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tresiba Flextouch 100 unit/mL 3mL, a prescription insulin product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $6,367.20, has a completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tresiba Flextouch insulin syringes, with a ceiling value of $4,002.12. The contract was awarded by the Defense Logistics Agency (DLA) on May 16, 2024, with a performance period ending on May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The award, valued at $1,532.20, is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 7, 2024. This...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,965.32 firm fixed-price delivery order is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a prescription insulin medication, to support the Department of Defense (DoD) and other government agencies. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Tresiba Flextouch insulin pens. The $30,687.31 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen's Corporate Office division. The contract has an ultimate completion date of October 14, 2022. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order worth $6,304.79 to supply TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, part of the Department of Defense, and has a period of performance through April 10, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order, valued at $5,458.35, is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL insulin pens. The contract has a completion date of August 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tresiba FlexTouch 200 Unit/mL 3mL insulin products. The contract has a ceiling value of $3,682.76 and spans from the award date of August 28, 2024, through the ultimate completion date of August 29, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $1,601.24, is for the delivery of Tresiba Flextouch insulin medication, a prescription drug used to treat diabetes. The contract has a completion date of February 2, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The $1,667.55 firm fixed price contract is for the delivery of Tresiba Flextouch 100 Unit/ML 3ML, a prescription diabetes medication. The contract has an ultimate completion date of June 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVGC8
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Tresiba FlexTouch insulin injections to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order valued at $2,193.51 with a completion date of July 9, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This order does not have a set-aside designation.

Generated 10/7/24, 10:39 AM